AVITA MEDICAL INC (RCEL)
US05380C1027 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to RCEL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.34. This target is 218.97% above the current price.
RCEL was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about RCEL.
In the previous month the buy percentage consensus was at a similar level.
RCEL was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-11 | BTIG | Downgrade | Buy -> Neutral |
| 2024-02-23 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-02-23 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-01-19 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-11-21 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-11-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-26 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-07-28 | B of A Securities | Maintains | Buy -> Buy |
| 2023-07-13 | Lake Street | Maintains | Buy -> Buy |
| 2023-06-27 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-05-12 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-04-17 | BTIG | Maintains | Buy |
| 2021-03-02 | Piper Sandler | Initiate | Overweight |